HighQC™ Feline Mesenchymal Stem Cell from Placenta

Description

HighQC™ Feline Mesenchymal Stem Cells (MSCs) from Placenta are isolated from neonatal feline placental tissue and exhibit robust multipotency, extended self-renewal, and strong proliferative ability. These cells represent a non-invasive and ethically acceptable source of MSCs, offering low immunogenicity and stable phenotypic characteristics. Compared to bone marrow-derived MSCs, placental MSCs demonstrate enhanced immunosuppressive functions and higher proliferative potential in vitro. Each cell batch undergoes cryopreservation and strict quality control measures to ensure consistency. Characterization includes confirmation of key MSC surface markers, including CD90, CD105, and CD44, verifying identity, purity, and functionality of the cells.

Application

• For research use only
  

• These Placenta-derived Feline Mesenchymal Stem Cells are valuable for investigating cellular mechanisms involved in inflammation, wound healing, and regenerative therapy. Their immunomodulatory functions and high proliferation rate make them suitable for use in co-culture assays, tissue repair models, and studies exploring veterinary stem cell therapies. The placenta offers a non-invasive, abundant source for MSCs, supporting their broader use in translational and experimental veterinary medicine.